Logo

Starry-Eyed CEO

Mar 12, 2007

Sidney Taurel, the chairman and CEO of Eli Lilly, has a sunny outlook on the progress in biomedical research. In the Boston Herald, he writes that this field has not fizzled out but is on the verge of discovering answers and cures to many diseases -- and it will be almost "miraculous." He notes that "human mortality will always equal 100 percent," but he sure seems confident that Lilly scientists will overcome all problems right up until the end. Or maybe he's just looking for new stockholders.

Breaking News
The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.